MicroLub: A novel microgel-based superlubricating formulation for fat replacement applications
MicroLub:一种基于微凝胶的新型超级润滑配方,适用于脂肪替代应用
基本信息
- 批准号:EP/X03514X/1
- 负责人:
- 金额:$ 16.47万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2023
- 资助国家:英国
- 起止时间:2023 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Reducing fat in foods is a viable strategy to significantly decrease calorie intake and thus, fat replacer molecules are likely to be important in the race towards reversing the obesity crisis. The commercial fat replacer market is expected to considerably increase to 24 billion Euros by 2027, largely fueled by the growing public awareness for reduced-fat foods. However, the fat replacer industry faces severe technological challenges because the currently marketed fat replacers do not fully emulate the lubrication performance of full fat counterparts and thus fail to achieve consumers' expectations. The aim of the MicroLub project is to translate an innovative microgel-based technology with superlubricity developed in the context of the ERC project LubSat, towards the development of a more effective fat replacer ingredient. The technological innovation proposed includes deformable polypeptide-based microgels with grafted saccharides in a patchy heterogenous morphology. The exposed polypeptide region lead to a transient colloidal coating of the oral surfaces via hydrophobic interactions, whilst the grafted saccharides hydrogen bond with water molecules to create a microporous hydrated scaffold. This technology thus combines boundary and fluid film lubrication, unachieved by any fat replacement technologies available to date. Working through 4 work-packages, we will validate the techno-commercial feasibility of the formulation in close cooperation with experienced industrial partners and create the framework for potential licensing of this breakthrough technology to key industrial players. The expected outcomes aim to demonstrate the up-scaling feasibility and validation of technical performance against competition, filing a licensable patent, and developing a provisional business model that will allow us to build strategic alliances with selected industrial partners to take forward the commercialization of this technology and finally contribute towards reducing obesity
减少食物中的脂肪是一个可行的策略,可显着减少卡路里的摄入量,因此,在逆转肥胖危机的比赛中,脂肪替代物分子可能很重要。预计到2027年,商业脂肪替代品市场预计将大大增加到240亿欧元,这在很大程度上是由于公众对减少脂肪食品的认识的越来越多。但是,脂肪替代品行业面临严重的技术挑战,因为当前销售的脂肪替代品并未完全模仿全脂脂肪的润滑性能,因此无法达到消费者的期望。 Microub项目的目的是翻译基于创新的微凝胶技术,其在ERC Project Lubsat的背景下开发了超纯度,以开发更有效的脂肪替代品成分。提出的技术创新包括在斑驳的异源形态中带有糖糖的可变形多肽的微凝胶。裸露的多肽区域通过疏水相互作用导致口腔表面的瞬时胶体涂层,而移植后的糖水氢键与水分子键形成微孔水分支架。因此,该技术结合了边界和流体膜润滑,迄今为止可用的任何脂肪替代技术未能实现。通过4个工作包工作,我们将与经验丰富的工业合作伙伴密切合作,验证该制定的技术商业可行性,并为对关键工业参与者的这种突破性技术的潜在许可创建框架。预期的结果旨在证明针对竞争,提交可授权专利的技术绩效的可行性和验证,并开发出临时业务模型,这将使我们能够与选定的工业合作伙伴建立战略性联盟,以推动这项技术的商业化,并最终有助于降低肥胖症
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glycation influencing lubrication: Tribology principles derived from nature to inspire future food colloid design
- DOI:10.1016/j.cocis.2023.101782
- 发表时间:2023-12
- 期刊:
- 影响因子:0
- 作者:A. Sarkar;Khalid Gul
- 通讯作者:A. Sarkar;Khalid Gul
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anwesha Sarkar其他文献
Gellan gum: A new member in the dysphagia thickener family
结冷胶:吞咽困难增稠剂家族的新成员
- DOI:
10.1016/j.biotri.2019.02.002 - 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Ophelie Torres;Ayuri Yamada;Neil M. Rigby;Takehisa Hanawa;Yayoi Kawano;Anwesha Sarkar - 通讯作者:
Anwesha Sarkar
Determining Integrin Molecular Tension for the Recruitment and the Activation of Focal Adhesion Kinase
- DOI:
10.1016/j.bpj.2018.11.670 - 发表时间:
2019-02-15 - 期刊:
- 影响因子:
- 作者:
Anwesha Sarkar;Yingxiao Wang;Xuefeng Wang - 通讯作者:
Xuefeng Wang
Effects of oral lubrication on satiety, satiation and salivary biomarkers in model foods: A pilot study
- DOI:
10.1016/j.appet.2021.105427 - 发表时间:
2021-10-01 - 期刊:
- 影响因子:
- 作者:
Ecaterina Stribițcaia;Catherine Gibbons;Joanna Sier;Christine Boesch;John Blundell;Graham Finlayson;Anwesha Sarkar - 通讯作者:
Anwesha Sarkar
Are video-based surveys feasible to assess the effect of food texture on perceived satiety?
- DOI:
10.1016/j.appet.2022.106227 - 发表时间:
2022-12-01 - 期刊:
- 影响因子:
- 作者:
Ecaterina Stribitcaia;John Blundell;Kwan-Mo You;Graham Finlayson;Catherine Gibbons;Anwesha Sarkar - 通讯作者:
Anwesha Sarkar
Understanding the effects of radioimmunotherapy on nanomechanical, viscoelastic properties of live glioblastoma cells using atomic force microscopy
- DOI:
10.1016/j.bpj.2023.11.2500 - 发表时间:
2024-02-08 - 期刊:
- 影响因子:
- 作者:
Nabila Masud;Nathan Faivre;Xuan Xuan Lee;Andrew E. Ekpenyong;Anwesha Sarkar - 通讯作者:
Anwesha Sarkar
Anwesha Sarkar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anwesha Sarkar', 18)}}的其他基金
PROTSENS Rethinking Alternative PROTein Extraction: Decoding SENsory-Protein Extraction Relationships
PROTSENS 重新思考替代性蛋白质提取:解码感觉-蛋白质提取关系
- 批准号:
EP/Z000785/1 - 财政年份:2024
- 资助金额:
$ 16.47万 - 项目类别:
Fellowship
相似国自然基金
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
- 批准号:82304677
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
- 批准号:82304658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
- 批准号:32171163
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10530989 - 财政年份:2022
- 资助金额:
$ 16.47万 - 项目类别:
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10672059 - 财政年份:2019
- 资助金额:
$ 16.47万 - 项目类别:
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10223925 - 财政年份:2019
- 资助金额:
$ 16.47万 - 项目类别:
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10673209 - 财政年份:2019
- 资助金额:
$ 16.47万 - 项目类别:
Targeted treatment of thrombotic occlusions using a dual-delivery microgel therapeutic
使用双重递送微凝胶治疗剂靶向治疗血栓闭塞
- 批准号:
10903125 - 财政年份:2019
- 资助金额:
$ 16.47万 - 项目类别: